{"cik":2075320,"taxonomy":"us-gaap","tag":"NetIncomeLoss","label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","entityName":"Polaryx Therapeutics, Inc.","units":{"USD":[{"start":"2024-01-01","end":"2024-12-31","val":-30356000,"accn":"0001213900-26-033064","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-24","frame":"CY2024"},{"start":"2025-01-01","end":"2025-03-31","val":-5052000,"accn":"0001213900-26-056973","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-15","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-06-30","val":-6060000,"accn":"0001213900-26-089118","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-13"},{"start":"2025-04-01","end":"2025-06-30","val":-1008000,"accn":"0001213900-26-089118","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-13","frame":"CY2025Q2"},{"start":"2025-01-01","end":"2025-12-31","val":-8985000,"accn":"0001213900-26-033064","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-24","frame":"CY2025"},{"start":"2026-01-01","end":"2026-03-31","val":-2544000,"accn":"0001213900-26-056973","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-15","frame":"CY2026Q1"},{"start":"2026-01-01","end":"2026-06-30","val":-3924000,"accn":"0001213900-26-089118","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-13"},{"start":"2026-04-01","end":"2026-06-30","val":-1380000,"accn":"0001213900-26-089118","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-13","frame":"CY2026Q2"}]}}